Skip to main content

Year: 2026

Sysco to Acquire Jetro Restaurant Depot to Expand into Higher-Margin, Growing, and Resilient Cash & Carry Channel

Transaction Combines Two Complementary Food-Away-From-Home Industry Leaders to Create Preeminent U.S. Multi-Channel Foodservice Distribution Platform Transaction Expected to be Immediately Accretive to Margins, EPS, and Free Cash Flow and Deliver Synergies Cash & Carry is a Large, Growing, Attractive, and Complementary Channel Serving Smaller Independent Foodservice Customers Combined Company Will Be More Profitable and Return More Value to Shareholders Combined Company to Enhance Value for Small Businesses and the Consumers They Serve by Expanding Access to More Affordable Products and Delivering More Choice and Convenience Jetro Restaurant Depot to Operate as a Standalone Business Segment Within Sysco Sysco Reaffirms Full Year 2026 Guidance; Q3 2026 USFS Local Volume Growth of Over 3.0% Sysco to Host Investor Conference Call Today...

Continue reading

Ellomay Capital to Sell its Indirect Holdings in Dorad Energy Ltd. based on a Dorad Valuation of NIS 4.4 Billion

Tel-Aviv, Israel, March 30, 2026 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today announced the results of the separation process with respect to Ellomay Luzon Energy Infrastructures Ltd. (“Ellomay Luzon Energy”), currently held in equal parts (50%-50%) by the Company (indirectly) and Amos Luzon Development and Energy Group Ltd. (the “Luzon Group”). Ellomay Luzon Energy’s main asset is its holding of 33.75% of Dorad Energy Ltd. (“Dorad”). The separation process was conducted on March 27, 2026, following the Israeli court’s ruling and the appointment of Judge (ret.) Hila Gerstel to act as the ruler regarding the separation process. The separation process resulted...

Continue reading

CBAK Energy Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results

DALIAN, China, March 30, 2026 (GLOBE NEWSWIRE) — CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy,” or the “Company”), a leading lithium-ion battery manufacturer and electric energy solution provider in China, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Financial and Operational HighlightsFourth Quarter Consolidated Net Revenues achieved an explosive 131.8% year-over-year growth, reaching $58.80 million, compared to $25.37 million in the fourth quarter of 2024. This hyper-growth in the top line effectively decoupled from the temporary bottom-line pressures caused by ongoing capacity transitions. Fourth Quarter Net Revenues from Light Electric Vehicles (LEV) skyrocketed by 524.1% year-over-year to $12.92 million, compared...

Continue reading

Neinor Homes (“Neinor”), Spain’s leading listed residential developer announces the launch of a share buyback program of up to 3 million shares, representing an investment of up to c.€50 million.

Neinor Homes Initiates €50M Share Repurchase Program: Capitalizing on DislocationNeinor announces a share buyback of up to 3 million shares (€50mn)Madrid, 30 March, 2026 – Neinor Homes (“Neinor”), Spain’s leading listed residential developer announces the launch of a share buyback program of up to 3 million shares, representing an investment of up to c.€50 million. The program will be used to meet obligations arising from share-based remuneration plans and to reduce share capital through the cancellation of treasury shares, contributing to shareholder remuneration and enhancing earnings per share. This initiative forms part of Neinor’s €500 million shareholder remuneration plan for the 2026–2027 period (€250 million per year), under which the Company has already distributed €92 million to shareholders. Borja García-Egotxeaga, CEO of...

Continue reading

Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights

– Written FDA recommendations include a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for schizophrenia – – Current data package highlights well-tolerated long-term safety profile, broad-spectrum clinical activity, and favorable adherence for once daily brilaroxazine up to one year – – Initiation of RECOVER-2 registrational trial planned in mid-2026 – CUPERTINO, Calif., March 30, 2026 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today reported financial results for the full year ended December 31,...

Continue reading

RCI Banque: ‘’Audited Consolidated Financial Statements as at December 31th 2025’’

March 30th, 2026 RCI Banque: ‘’Audited Consolidated Financial Statements as at December 31th 2025’’ The RCI BANQUE: Audited Consolidated Financial Statements as at December 31th 2025 is now available on the Mobilize Financial Services website www.mobilize-fs.comAttachmentRCI Banque Consolidated financial statements – EN 2025

Continue reading

Form 8.3 – [IDOX PLC – 27 03 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

GXO Expands Partnership with NHS England

GXO will manage the provision of national bowel cancer home testing kits for NHS England LONDON, U.K., March 30, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, continues its expansion in healthcare logistics with the announcement today of its appointment by NHS England as the managed service provider for the continued provision of Faecal Immunochemical Test (FIT) home testing for eligible participants in the bowel cancer screening programme across England. As part of the agreement, GXO will manage the supply and distribution of FIT kits working with best-in-class partners, MAST, the world’s largest distributor of FITs and RDi, the UK’s leading end-to-end diagnostic kitting partner. “GXO’s solutions are purpose-built for the complex and highly regulated needs of...

Continue reading

AL Sydbank A/S share buyback programme: transactions in week 13

        Company Announcement No 15/2026Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37 AL Sydbank A/SCVR No DK 12626509, Aabenraaal-sydbank.com30 March 2026  Dear Sirs AL Sydbank A/S share buyback programme: transactions in week 13On 25 February 2026 AL Sydbank A/S announced a share buyback programme of DKK 1,100m. The share buyback programme commenced on 2 March 2026 and will be completed by 31 January 2027. The purpose of the share buyback programme is to reduce the share capital of AL Sydbank A/S and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.